The landscape of managing diabetes is advancing with the arrival of transdermal GLP-1 delivery . These innovative devices offer a potentially less invasive alternative to injections for individuals dealing with diabetes mellitus type 2 . Such a system deliver glucagon-like peptide-1 directly through the epidermis, avoiding the need for daily inj… Read More